Category D

Research Ethics & Reporting

Human and animal research, consent, trial registration, reporting standards, biological materials, biosafety and related ethical requirements.

5 policy instruments 19 controlled terms

Policies in this category

LMI-POL-014

Human Research Ethics, Consent & Participant Protection

Establishes the minimum ethical prerequisites for publishing research involving human participants, identifiable human data or biological material: prior ethics approval or a properly granted waiver, valid informed consent, separate publication consent for identifiable information, safeguards for vulnerable participants and minors, privacy, online and observational research, audits and quality-improvement activity, community-governed research, biobanks, genetics and other sensitive human materials. Defines the journal’s verification role and its limits.

Publisher + Journal Policy Version 1.0
LMI-POL-015

Animal Research Ethics & Welfare

Establishes minimum requirements for publishing research involving animals: documented prospective ethical oversight under the applicable national and institutional framework, justification of animal use, application of replacement, reduction and refinement, humane care and welfare endpoints, and transparent reporting consistent with recognised animal-research reporting guidance.

Publisher + Journal Policy Version 1.0
LMI-POL-016

Clinical Trial Registration & Prospective Transparency

Requires applicable clinical trials to be registered prospectively in a recognised public registry, with the registration number reported and the registry entry consistent with the manuscript. Governs protocol transparency, material deviations and outcome changes, and permits only rare, documented and prominently disclosed exceptions for late registration after an assessment of potential reporting bias.

Publisher + Journal Policy Version 1.0
LMI-STD-001

Research Reporting Standards

Requires each journal to implement design-appropriate reporting guidelines, using current versions and recognised sources such as the EQUATOR Network, while leaving checklist mechanics, submission requirements and enforcement points to journal-level implementation. Clarifies that reporting-guideline compliance improves transparency but does not by itself establish methodological quality.

Journal Implementation Standard Version 1.0
LMI-POL-017

Dual-Use, Biosafety & Potentially Harmful Research

Establishes how LMI journals identify and handle research whose dissemination could create unusual risk to public health, safety or security — including dual-use research, dangerous pathogen work, and safety-sensitive technical detail. Requires proportionate assessment weighing scientific benefit, foreseeable harm, legal and ethical obligations and possible mitigation, with specialist consultation and publisher escalation, and expressly bars use of the policy to suppress uncomfortable but legitimate research.

Publisher + Journal Policy Version 1.0

Category glossary

Definitions shown here are canonical framework definitions. A term may be used across several policies while retaining one controlled meaning.

Human participant

A living person about whom, or from whom, a researcher obtains data, samples or identifiable information through intervention or interaction, including persons whose identifiable records or material are studied.

Primary policy home: LMI-POL-014 · Human Research Ethics, Consent & Participant Protection
Research ethics committee / institutional review board (IRB)

A duly constituted body competent under the applicable national or institutional framework to review and approve research involving humans, and to grant waivers within its authority.

Primary policy home: LMI-POL-014 · Human Research Ethics, Consent & Participant Protection
Informed consent

Voluntary agreement to participate in research, given with adequate understanding of purpose, procedures, risks, benefits and data handling, by a person with capacity or an authorised representative, documented as required and freely revocable.

Primary policy home: LMI-POL-014 · Human Research Ethics, Consent & Participant Protection
Consent for publication

Explicit, specific and documented consent to the publication of identifiable information, images or case details, given with knowledge that publication will be public and permanent. Distinct from, and not implied by, consent to participate.

Primary policy home: LMI-POL-014 · Human Research Ethics, Consent & Participant Protection
Vulnerable participant

A participant whose capacity to consent freely or fully may be limited by age, capacity, dependency, confinement, displacement, acute distress or unequal power, requiring additional safeguards.

Primary policy home: LMI-POL-014 · Human Research Ethics, Consent & Participant Protection
Ethics waiver

A documented decision by a competent ethics body dispensing with individual consent within a defined scope, on grounds permitted by the applicable framework.

Primary policy home: LMI-POL-014 · Human Research Ethics, Consent & Participant Protection
Clinical trial

A prospective study assigning human participants to interventions to evaluate health-related effects, as understood in recognised international definitions.

Primary policy home: LMI-POL-016 · Clinical Trial Registration & Prospective Transparency
Prospective registration

Entry of a trial in a recognised public registry before enrolment of the first participant. Registration after enrolment is late registration and is not equivalent.

Primary policy home: LMI-POL-016 · Clinical Trial Registration & Prospective Transparency
Trial registry

A publicly accessible, free registry meeting recognised standards including a minimum dataset — a WHO ICTRP primary registry, ClinicalTrials.gov, or an equivalent. Proprietary or non-public records do not qualify.

Primary policy home: LMI-POL-016 · Clinical Trial Registration & Prospective Transparency
Protocol

The document specifying a study's objectives, design, participants, interventions, outcomes and analysis plan, with version and date, against which conduct and reporting are assessed.

Primary policy home: LMI-POL-016 · Clinical Trial Registration & Prospective Transparency
Reporting guideline

A recognised, design-specific statement of the minimum information a research report should contain, catalogued by sources such as the EQUATOR Network, applied in its current version under D4.

Primary policy home: LMI-STD-001 · Research Reporting Standards
Dual-use research (of concern)

Research reasonably anticipated to provide knowledge, products or technologies that could be directly misapplied to pose a significant threat to public health, safety, agriculture, the environment or security.

Primary policy home: LMI-POL-017 · Dual-Use, Biosafety & Potentially Harmful Research
Biosafety

Containment principles, technologies and practices preventing unintentional exposure to, or release of, biological agents.

Primary policy home: LMI-POL-017 · Dual-Use, Biosafety & Potentially Harmful Research
Biosecurity

Measures preventing loss, theft, misuse, diversion or intentional release of biological agents, related materials or associated information.

Primary policy home: LMI-POL-017 · Dual-Use, Biosafety & Potentially Harmful Research
Biobank

An organised collection of human biological specimens and associated data maintained under documented consent, ethics and governance arrangements for current or future research.

Primary policy home: LMI-POL-014 · Human Research Ethics, Consent & Participant Protection
Broad consent

Consent permitting a defined range of future research uses under stated governance conditions. It is not unrestricted consent and does not authorise uses outside the scope communicated to participants.

Primary policy home: LMI-POL-014 · Human Research Ethics, Consent & Participant Protection
Community-governed data or material

Data, specimens, knowledge or remains subject to legitimate collective, cultural, Indigenous or custodial governance in addition to any individual consent requirements.

Primary policy home: LMI-POL-014 · Human Research Ethics, Consent & Participant Protection
Genetic and genomic data

Information about inherited or acquired genetic material that may identify individuals, relatives or populations and may therefore require heightened privacy, access and community safeguards.

Primary policy home: LMI-POL-014 · Human Research Ethics, Consent & Participant Protection
Provenance

The documented origin, collection context, ownership or custodianship, transfers and permitted use of biological material, data or culturally governed resources.

Primary policy home: LMI-POL-014 · Human Research Ethics, Consent & Participant Protection